Dissecting the ACC/AHA Lipid Guidelines: Where Do We Stand?

1st Women’s Heart and Vascular Symposium

K. Vijay

Zodasiran Silences Hepatic ANGPTL3 Leading to Deep and Durable Reduc…

Robert Rosenson

What’ll be New in Lipid Management in 2023? Rethinking the Paradigms

Top Ten Topics in Clinical Cardiology 2022

R. Rosenson

Familial Hypercholesterolemia: What You Need to Know

McMaster University Department of Medicine

R. Hegele

Pearls from 34 Years of Running a Lipid Clinic

National Lipid Association

A. Brown

EADV 2023 Insights: Insulin Resistance in Acanthosis Nigricans

EADV 2023 Insights

S. Feldman

Management of Dyslipidemia in 2024: A Case-Based Approach

University of Louisville

D. Kalra

Beyond LDL: Assessing and Treating Residual ASCVD Risk

University of Colorado Department of Medicine

M. Cornier

Comparison 2013 and 2018 Cholesterol Guidelines in Secondary Prevent…

National Lipid Association

C. Orringer

Improving Cardiovascular Screening in Patients With Psoriasis

Joel M. Gelfand

Improved Identification, Diagnosis, and Management of Homozygous Fam…

Integrity CE

R. Rosenson

Pediatric Lipidology - Is There a Need for More Training and Availab…

National Lipid Association

A. Ware

Heart Disease Prevention and Early Detection

Scripps Health

C. Adams

Update on the Management of Hypercholesterolemia

Cleveland Clinic Endocrinology & Metabolism Institute

B. Carranza Leon

Familial Hypercholesterolemia: From Diagnosis to Treatment

Scripps Health

P. Duell

ACC/AHA Cholesterol Guideline: How to Handle the High-Risk Patients

National Lipid Association

K. Birtcher

Genetic Testing in Preventive Cardiology: Are Those With FH Mutation…

ASPC 2020 Virtual Summit on CVD Prevention

A. Khera

Familial Hypercholesterolemia

The American Society for Preventive Cardiology

S. Baum